332 related articles for article (PubMed ID: 23299882)
1. A safe lithium mimetic for bipolar disorder.
Singh N; Halliday AC; Thomas JM; Kuznetsova OV; Baldwin R; Woon EC; Aley PK; Antoniadou I; Sharp T; Vasudevan SR; Churchill GC
Nat Commun; 2013; 4():1332. PubMed ID: 23299882
[TBL] [Abstract][Full Text] [Related]
2. Effects of the putative lithium mimetic ebselen on pilocarpine-induced neural activity.
Singh N; Serres F; Toker L; Sade Y; Blackburn V; Batra AS; Saiardi A; Agam G; Belmaker RH; Sharp T; Vasudevan SR; Churchill GC
Eur J Pharmacol; 2020 Sep; 883():173377. PubMed ID: 32687920
[TBL] [Abstract][Full Text] [Related]
3. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
Atack JR; Broughton HB; Pollack SJ
Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
[TBL] [Abstract][Full Text] [Related]
4. Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing.
Masaki C; Sharpley AL; Cooper CM; Godlewska BR; Singh N; Vasudevan SR; Harmer CJ; Churchill GC; Sharp T; Rogers RD; Cowen PJ
Psychopharmacology (Berl); 2016 Jul; 233(14):2655-61. PubMed ID: 27256357
[TBL] [Abstract][Full Text] [Related]
5. Inositol-deficient food augments a behavioral effect of long-term lithium treatment mediated by inositol monophosphatase inhibition: an animal model with relevance for bipolar disorder.
Shtein L; Agam G; Belmaker RH; Bersudsky Y
J Clin Psychopharmacol; 2015 Apr; 35(2):175-7. PubMed ID: 25679134
[TBL] [Abstract][Full Text] [Related]
6. Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla.
Masaki C; Sharpley AL; Godlewska BR; Berrington A; Hashimoto T; Singh N; Vasudevan SR; Emir UE; Churchill GC; Cowen PJ
Psychopharmacology (Berl); 2016 Mar; 233(6):1097-104. PubMed ID: 26758281
[TBL] [Abstract][Full Text] [Related]
7. Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.
Singh N; Sharpley AL; Emir UE; Masaki C; Herzallah MM; Gluck MA; Sharp T; Harmer CJ; Vasudevan SR; Cowen PJ; Churchill GC
Neuropsychopharmacology; 2016 Jun; 41(7):1768-78. PubMed ID: 26593266
[TBL] [Abstract][Full Text] [Related]
8. Structural and biochemical analysis of human inositol monophosphatase-1 inhibition by ebselen.
Abuhammad A; Laurieri N; Rice A; Lowe ED; Singh N; Naser SM; Ratrout SS; Churchill GC
J Biomol Struct Dyn; 2023; 41(23):14036-14048. PubMed ID: 36762717
[TBL] [Abstract][Full Text] [Related]
9. Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression.
Kofman O; Belmaker RH
Biol Psychiatry; 1993 Dec; 34(12):839-52. PubMed ID: 8110911
[TBL] [Abstract][Full Text] [Related]
10. Lithium Pharmacogenetics: Where Do We Stand?
Pisanu C; Melis C; Squassina A
Drug Dev Res; 2016 Nov; 77(7):368-373. PubMed ID: 27633500
[TBL] [Abstract][Full Text] [Related]
11. The putative lithium-mimetic ebselen reduces impulsivity in rodent models.
Barkus C; Ferland JN; Adams WK; Churchill GC; Cowen PJ; Bannerman DM; Rogers RD; Winstanley CA; Sharp T
J Psychopharmacol; 2018 Sep; 32(9):1018-1026. PubMed ID: 29986609
[TBL] [Abstract][Full Text] [Related]
12. Ebselen has lithium-like effects on central 5-HT
Antoniadou I; Kouskou M; Arsiwala T; Singh N; Vasudevan SR; Fowler T; Cadirci E; Churchill GC; Sharp T
Br J Pharmacol; 2018 Jul; 175(13):2599-2610. PubMed ID: 29488218
[TBL] [Abstract][Full Text] [Related]
13. Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs.
Agam G; Shamir A; Shaltiel G; Greenberg ML
Bipolar Disord; 2002; 4 Suppl 1():15-20. PubMed ID: 12479670
[TBL] [Abstract][Full Text] [Related]
14. High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy.
Gill R; Mohammed F; Badyal R; Coates L; Erskine P; Thompson D; Cooper J; Gore M; Wood S
Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):545-55. PubMed ID: 15858264
[TBL] [Abstract][Full Text] [Related]
15. Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy.
Shamir A; Ebstein RP; Nemanov L; Zohar A; Belmaker RH; Agam G
Mol Psychiatry; 1998 Nov; 3(6):481-2. PubMed ID: 9857972
[No Abstract] [Full Text] [Related]
16. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
Vadnal R; Parthasarathy R
Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
[TBL] [Abstract][Full Text] [Related]
17. Defective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis.
Ohnishi T; Murata T; Watanabe A; Hida A; Ohba H; Iwayama Y; Mishima K; Gondo Y; Yoshikawa T
J Biol Chem; 2014 Apr; 289(15):10785-10796. PubMed ID: 24554717
[TBL] [Abstract][Full Text] [Related]
18. Crystallization and structure of ebselen bound to Cys141 of human inositol monophosphatase.
Fenn GD; Waller-Evans H; Atack JR; Bax BD
Acta Crystallogr F Struct Biol Commun; 2020 Oct; 76(Pt 10):469-476. PubMed ID: 33006574
[TBL] [Abstract][Full Text] [Related]
19. Regulation of inositol monophosphatase in Saccharomyces cerevisiae.
Murray M; Greenberg ML
Mol Microbiol; 1997 Aug; 25(3):541-6. PubMed ID: 9302016
[TBL] [Abstract][Full Text] [Related]
20. Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.
Faraci WS; Zorn SH; Bakker AV; Jackson E; Pratt K
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):369-74. PubMed ID: 8387266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
